机构：[1]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.神经科系统神经内科首都医科大学宣武医院[2]Department of Neurology, Sir Run Run Shaw Hospital, Affiliated with School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.[3]Department of Neurology, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, China.[4]Heilongjiang Key Laboratory of Ischemic Stroke Prevention and Treatment, Mudanjiang, Heilongjiang 157011, China.[5]Department of Neurology, Tangshan Central Hospital, Tangshan, Hebei 063000, China.[6]Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of the Ministry of Education, Beijing 100053, China.科技平台神经变性病教育部重点实验室首都医科大学宣武医院[7]Institute for Advanced Communication and Data Science, Shanghai University, Shanghai 200444, China.[8]Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.医技科室放射科首都医科大学宣武医院[9]Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing 100053, China.[10]Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing 100053, China.[11]School of Biomedical Engineering, Hainan University, Haikou, Hainan 570228, China.[12]Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing 100053, China.[13]National Clinical Research Center for Geriatric Disorders, Beijing 100053, China.[14]Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong 518132, China.
This work was supported by grants from the National
Natural Science Foundation of China (Nos. 82020108013
and 82001773), National Key Research and Development
Program of China (No. 2022YFC24069004), Beijing Brain Initiative from Beijing Municipal Science & Technology Commission (Z201100005520018), and STI2030-
Major Projects (No. 2022ZD0211800).
第一作者机构：[1]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.
通讯作者：
通讯机构：[1]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.[11]School of Biomedical Engineering, Hainan University, Haikou, Hainan 570228, China.[12]Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing 100053, China.[13]National Clinical Research Center for Geriatric Disorders, Beijing 100053, China.[14]Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong 518132, China.[*1]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714)：
Zhang Mingkai,Wang Xiaoni,Zhao Weina,et al.Subjective cognitive decline domain improves accuracy of plasma Aβ42/Aβ40 for preclinical Alzheimer's disease diagnosis: The SILCODE study[J].CHINESE MEDICAL JOURNAL.2024,137(9):1127-1129.doi:10.1097/CM9.0000000000002851.
APA：
Zhang Mingkai,Wang Xiaoni,Zhao Weina,Li Yuxia,Ying Chao...&Han Ying.(2024).Subjective cognitive decline domain improves accuracy of plasma Aβ42/Aβ40 for preclinical Alzheimer's disease diagnosis: The SILCODE study.CHINESE MEDICAL JOURNAL,137,(9)
MLA：
Zhang Mingkai,et al."Subjective cognitive decline domain improves accuracy of plasma Aβ42/Aβ40 for preclinical Alzheimer's disease diagnosis: The SILCODE study".CHINESE MEDICAL JOURNAL 137..9(2024):1127-1129
